Skip to main content

Table 2 99mTc-PYP findings from planar and quantitative SPECT

From: Assessment of cardiac amyloidosis with 99mTc-pyrophosphate (PYP) quantitative SPECT

Groups

Total (n = 37)

Group A: ATTR cardiac amyloidosis (n = 6)

Group B: AL cardiac amyloidosis (n = 10)

Group C: others (n = 21)

p value

Planar

 Visual scores (%)

  0

8.1

0

0

14.3

< 0.0001

  1

73

0

100

81

  2

8.1

33.3

0

4.8

  3

10.8

66.7

0

0

 H/CL ratio

1.45 ± 0.31

1.98 ± 0.29

1.28 ± 0.16*

1.38 ± 0.19*

< 0.0001

Quantitative SPECT

 SUVmax

2.88 ± 2.36

7.50 ± 2.68^,^^

1.96 ± 0.35

2.00 ± 0.74

0.002

 SUVmedian

2.38 ± 1.90

6.17 ± 1.92^,^^

1.65 ± 0.39

1.65 ± 0.60

0.001

 SUVmean

2.36 ± 1.90

6.16 ± 1.90^,^^

1.61 ± 0.40

1.63 ± 0.60

0.001

 SUVbone

1.09 ± 0.29

1.17 ± 0.34

1.28 ± 0.22**

0.97 ± 0.25

0.01

  1. Continuous data are expressed as mean ± SD, and categorical data are expressed as percentages
  2. *p < 0.05 by ANOVA with Bonferroni correction in comparison to Group A
  3. **p < 0.05 by ANOVA with Bonferroni correction in comparison to Group C
  4. ^p < 0.05 by Welch ANOVA with Games-Howell correction in comparison to Group B
  5. ^^p < 0.05 by Welch ANOVA with Games-Howell correction in comparison to Group C